Loading clinical trials...
Loading clinical trials...
Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-Typhoidal Salmonella Disease (VINS)
Conditions
Interventions
R21/Matrix-M malaria vaccine
Locations
1
Democratic Republic of the Congo
Institut National de Recherche Biomedicale (INRB)
Kinshasa, Democratic Republic of the Congo
Start Date
October 27, 2025
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2027
Last Updated
February 18, 2026
NCT07074665
NCT06967519
NCT06068530
NCT07269314
NCT05690841
NCT06854042
Lead Sponsor
International Vaccine Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions